-
Chinese Citizen Allegedly Casts Ballot in US Election; Temu to Be Investigated by EU -
China Halts Foreign Adoptions After 32 Years
-
Only 0.3 Percent of COVID Vaccine Injury Claims Compensated by US Program | Facts Matter
-
Vaccine Manufacturer Finally Admits to Stroke Side Effect | Facts Matter
-
43 Percent of Small Businesses Had Trouble Paying April Rent: Report | Business Matters Full Broadcast (April 29)
-
AstraZeneca Capping Inhaler Costs for Eligible Customers at $35 From June 1
-
Judge Dismisses AstraZeneca’s Challenge to Medicare Drug Price Negotiation
-
Biden Administration Begins Medicare Drug Price Negotiations
-
US Public Pension Funds Pour Money Into China
-
Actress Sues AstraZeneca, Alleging COVID-19 Jab Left Her With Brain Injuries
-
Class Action Lawsuit Against AstraZeneca for Vaccine Injury Moves Forward
-
AstraZeneca Signs Deal With China’s CanSino on mRNA Vaccines
-
Successful COVID-19 Vaccine Injury Claims Double in 3 Months
-
FDA Panel Backs Restricted Use of AstraZeneca’s Prostate Cancer Drug
-
Coroner Confirms Earliest Known UK Death From AstraZeneca Vaccine
-
Risk of Cardiac Death Tripled for Young Women Following AstraZeneca COVID-19 Vaccination: Study
-
Major Countries Officially Report 100 Deaths Caused by COVID-19 Vaccines
-
Senators Call for Release of COVID-19 Vaccine Agreements
-
Another Study Finds COVID-19 Vaccine Effectiveness Turns Negative Within Months
-
AstraZeneca’s COVID Vaccine Suffers a Setback in Nasal Spray Trial
-
EU Regulator Backs Wider Use of AstraZeneca COVID-19 Therapy
-
AstraZeneca Beats US Shareholder Lawsuit Over COVID-19 Vaccine Disclosures
-
Annual COVID-19 Boosters May Not Be Good Use of Resources: AstraZeneca Boss
-
AstraZeneca Lifts Revenue Guidance on COVID-19 Treatment
-
AstraZeneca to Buy Oncology Firm TeneoTwo for Up to $1.27 Billion
-
Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination
-
‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
